论文部分内容阅读
[目的]观察慢阻肺合并气胸患者行微创式胸腔闭式引流治疗疗效。[方法]慢阻肺合并气胸患者53例,随机分为治疗组与对照组,治疗组予中心静脉导管行胸腔闭式引流治疗。对照组予常规胸腔闭式引流治疗。两组均给予抗感染、氧疗等对症、支持治疗。两组患者进行治愈率、手术时间、疼痛程度、引流时间对比评定。[结果]两组在治愈率、引流时间上差异均无统计学意义(P﹥0.5)。而在手术时间、疼痛程度上差异有统计学意义(P﹤0.001)。[结论]常规胸腔闭式引流与中心静脉套管行微创式胸腔闭式引流,其2者都可有效治愈气胸,而微创式胸腔闭式引流更能减轻疼痛,减少手术时间,更易为慢阻肺患者所接受,亦更具安全性。
[Objective] To observe the curative effect of minimally invasive thoracic closed drainage in patients with COPD and pneumothorax. [Method] Fifty-three patients with chronic obstructive pulmonary disease and pneumothorax were randomly divided into treatment group and control group. The treatment group was treated by thoracic closed drainage with central venous catheter. The control group was treated with closed thoracic drainage. Both groups were given anti-infection, oxygen therapy and other symptomatic, supportive treatment. Two groups of patients were cured, operative time, pain, drainage time comparison assessment. [Results] There was no significant difference between the two groups in cure rate and drainage time (P> 0.5). However, there was significant difference in the degree of pain at the time of operation (P <0.001). [Conclusion] Conventional closed thoracic drainage and central venous cannula with minimally invasive thoracic closed drainage, both of which can effectively cure pneumothorax, and minimally invasive thoracic drainage can reduce pain, reduce the operation time, more easily Patients with COPD receive more safety.